Evidence map›Paper›PMID 25653412›Full record

ArticleJournal of clinical microbiology2015

Improved serodiagnosis of bovine brucellosis by novel synthetic oligosaccharide antigens representing the capping m epitope elements of Brucella O-polysaccharide.

John McGiven, Laurence Howells, Lucy Duncombe, Judy Stack, N Vijaya Ganesh, Julie Guiard, David R Bundle

Open access · bronzeAbstract readComparative StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. False Positives in Brucellosis Serology: Wrong Bait and Wrong Pond?Tropical medicine and infectious disease · 2023
    Review
  10. Review
  11. The Tip ofMicroorganisms · 2022
    Article
  12. NaturalVaccines · 2022
    Article
  13. Review
  14. Immunization withVaccines · 2021
    Article
  15. Article
  16. Bovine brucellosis - a comprehensive review.The veterinary quarterly · 2021
    Review
  17. Laboratory Diagnosis of Human Brucellosis.Clinical microbiology reviews · 2019
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

John McGivenFAO/WHO Collaborating Centre for Brucellosis, OIE Brucellosis Reference Centre, Department of Bacteriology, Animal & Plant Health Agency, Addlestone, Surrey, United Kingdom john.mcgiven@apha.gsi.gov.uk.
Laurence HowellsFAO/WHO Collaborating Centre for Brucellosis, OIE Brucellosis Reference Centre, Department of Bacteriology, Animal & Plant Health Agency, Addlestone, Surrey, United Kingdom.
Lucy DuncombeFAO/WHO Collaborating Centre for Brucellosis, OIE Brucellosis Reference Centre, Department of Bacteriology, Animal & Plant Health Agency, Addlestone, Surrey, United Kingdom.
Judy StackFAO/WHO Collaborating Centre for Brucellosis, OIE Brucellosis Reference Centre, Department of Bacteriology, Animal & Plant Health Agency, Addlestone, Surrey, United Kingdom.
N Vijaya GaneshDepartment of Chemistry, University of Alberta, Edmonton, Alberta, Canada.
Julie GuiardDepartment of Chemistry, University of Alberta, Edmonton, Alberta, Canada.
David R BundleDepartment of Chemistry, University of Alberta, Edmonton, Alberta, Canada.
Animal and Plant Health Agency · GBUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Members of the genus Brucella have cell wall characteristics of Gram-negative bacteria, which in the most significant species includes O-polysaccharide (OPS). Serology is the most cost-effective means of detecting brucellosis, as infection with smooth strains of Brucella leads to the induction of high antibody titers against the OPS, an unbranched homopolymer of 4,6-dideoxy-4-formamido-D-mannopyranosyl residues (D-Rha4NFo) that are variably α(1→2)- and α(1→3)-linked. Six d-Rha4NFo homo-oligosaccharides were synthesized, each containing a single α(1→3) link but with a varied number of α(1→2) links. After conjugation to bovine serum albumin (BSA), glycoconjugates 1 to 6 were used to develop individual indirect enzyme-linked immunosorbent assays (iELISAs). The diagnostic capabilities of these antigens were applied to panels of cattle serum samples, including those falsely positive in conventional assays, and the results were compared with those of the complement fixation test (CFT), serum agglutination test (SAT), fluorescent polarization assay (FPA), smooth lipopolysaccharide (sLPS) iELISA, and competitive enzyme-linked immunosorbent assay (cELISA) methods. Results from field serum samples demonstrated that all of the synthetic antigens had excellent diagnostic capabilities. Assays developed with the α(1→3)-linked disaccharide conjugate 1 were the best at resolving false-positive serological results. This was supported by the results from serum samples derived from experimentally infected cattle. Data from synthetic trisaccharide antigens 2 and 3 and tetrasaccharide antigen 4 identified an OPS epitope equally common to all Brucella abortus and Brucella melitensis strains but unique to Brucella. Synthetic oligosaccharide conjugates function as effective surrogates for naturally derived antigens. The creation of discrete OPS epitope antigens reveals not only the previously untapped diagnostic potential within this key diagnostic structure but also holds significance for the design of brucellosis vaccines and diagnostics that enable the differentiation of infected from vaccinated animals.

Indexed as

AnimalsAntibodies, BacterialAntigens, BacterialBrucella abortusBrucella melitensisBrucellosis, BovineCattleEnzyme-Linked Immunosorbent AssayEpitopesOligosaccharidesSerologic TestsAntibodies, BacterialAntigens, BacterialEpitopesOligosaccharides

Identifiers

PMID25653412
PMCPMC4365195
OpenAlexW2035094548

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.